Dilution of Share Value Resulting from the Exercise of Share Acquisition Rights
First written in FY2023. 6 of 10 entries say "Materialised", first in FY2024-Q1. Latest entry: FY2026.
Foodison moved to the "Worse" side of this theme in 2023, 2 years after the typical company in this theme (2021).
The whole theme swung hardest in 2017: 34 of 62 companies on the "Worse" side.
5 other companies' latest entry also says "Other".
- FY2026Continued exercise and decline in potential sharesAnnual report
「As of the end of May 2026, the number of potential shares associated with these share acquisition rights was 221,000, equivalent to 4.54% of the total of 4,868,640 issued shares and potential shares.」
While the exercise of share acquisition rights covering 47,100 shares occurred during the fiscal year ending March 2026, the number of potential shares declined from 288,300, or 5.90%, to 221,000, or 4.54%. - 2026-05-15MaterialisedRevision to earnings forecast
「Issuance of new shares (exercise of share acquisition rights)」
当期にも新株予約権の行使による新株発行が発生し、株式発行による収入30,810千円を計上した。希薄化要因の発生が継続している。 - FY2026-H1MaterialisedAnnual report
「1 April 2025–30 September 2025 Note 38,000 4,633,140 12,360 890,022 12,360 32,460 Note: Through the exercise of share acquisition rights.」
During the interim consolidated accounting period, 38,000 shares were issued through the exercise of share acquisition rights, bringing the total number of issued shares to 4,633,140. Dilution events resulting from the exercise of share acquisition rights continue to occur. - FY2025WorsenedAnnual report
「As of the end of May 2025, the number of potential shares associated with these share acquisition rights was 288,300, equivalent to 5.90% of the total of 4,883,440 issued shares and potential shares.」
The number of potential shares increased from 245,600, or 5.14%, in the previous disclosure, indicating greater potential dilution. During the fiscal year ending March 2025, 51,300 shares were also issued through the exercise of share acquisition rights. - FY2025-H1WorsenedAnnual report
「1 April 2024–26 July 2024 Note 1 13,500 4,543,840 4,762 862,325 4,762 1,649,424 28 July 2024–30 September 2024 Note 1 9,500 4,553,340 3,252 865,577 3,252 8,015 Note 1. Through the exercise of share acquisition rights.」
During the interim consolidated accounting period, a total of 23,000 shares were issued through the exercise of share acquisition rights, and additional rights covering 106,000 shares were granted. Potential dilution factors have been added. - FY2024MaterialisedAnnual report
「Between 1 April 2023 and 31 March 2024, the total number of issued shares increased by 124,900 shares through the exercise of share acquisition rights, while capital and capital surplus each increased by ¥30.8 million.」
The issuance of shares through the exercise of share acquisition rights also occurred during the fiscal year. As of the filing date, the number of potential shares was 245,600, representing 5.14% of the total of issued shares and potential shares. - FY2024-Q3MaterialisedAnnual report
「1 October 2023–31 December 2023 (Note) 1 25,200 4,464,640 6,210 843,657 6,210 1,630,756 (Note) 1. Resulting from the exercise of share acquisition rights. (Note) 2. Between 1 January 2024 and 31 January 2024, the total number of issued shares increased by 43,500 through the exercise of share acquisition rights, while capital stock and capital surplus each increased by ¥6.532 million.」
During the third quarter, 25,200 shares were issued through the exercise of share acquisition rights, and a further 43,500 shares were issued in January 2024. Events relating to dilution continue to occur in practice. - FY2024-Q2MaterialisedAnnual report
「1 July 2023–30 September 2023 (Note) 1 24,900 4,439,440 8,327 837,447 8,327 1,624,546 (Note) 1. Resulting from the exercise of share acquisition rights. The total number of issued shares increased by 2,000 through the exercise of share acquisition rights between 1 October 2023 and 31 October 2023.」
During the second quarter, 24,900 shares were issued through the exercise of share acquisition rights, and a further increase of 2,000 shares occurred in October. Events relating to dilution continue to occur in practice. - FY2024-Q1MaterialisedAnnual report
「1 April 2023–30 June 2023 (Note) 1 9,100 4,414,540 2,357 829,120 2,357 1,616,219 (Note) 1. Resulting from the exercise of share acquisition rights.」
During the first quarter, 9,100 shares were issued through the exercise of share acquisition rights, and a further 18,000 shares were issued by the filing date. Events relating to dilution of equity value through the exercise of share acquisition rights have actually occurred. - FY2023First statedAnnual report
「As of the end of May 2023, the number of potential shares related to these share acquisition rights was 374,400, equivalent to 7.83% of the total of 4,781,840 issued shares and potential shares.」
The disclosure addresses the potential dilution of existing shareholders' equity value and voting interests through the exercise of share acquisition rights, as well as the possibility of shares entering the market.